» Articles » PMID: 30642750

Development and Validation of a Magnetic Resonance Imaging-based Model for the Prediction of Distant Metastasis Before Initial Treatment of Nasopharyngeal Carcinoma: A Retrospective Cohort Study

Overview
Journal EBioMedicine
Date 2019 Jan 16
PMID 30642750
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We aimed to identify a magnetic resonance imaging (MRI)-based model for assessment of the risk of individual distant metastasis (DM) before initial treatment of nasopharyngeal carcinoma (NPC).

Methods: This retrospective cohort analysis included 176 patients with NPC. Using the PyRadiomics platform, we extracted the imaging features of primary tumors in all patients who did not exhibit DM before treatment. Subsequently, we used minimum redundancy-maximum relevance and least absolute shrinkage and selection operator algorithms to select the strongest features and build a logistic model for DM prediction. The independent statistical significance of multiple clinical variables was tested using multivariate logistic regression analysis.

Findings: In total, 2780 radiomic features were extracted. A DM MRI-based model (DMMM) comprising seven features was constructed for the classification of patients into high- and low-risk groups in a training cohort and validated in an independent cohort. Overall survival was significantly shorter in the high-risk group than in the low-risk group (P < 0·001). A radiomics nomogram based on radiomic features and clinical variables was developed for DM risk assessment in each patient, and it showed a significant predictive ability in the training [area under the curve (AUC), 0·827; 95% confidence interval (CI), 0.754-0.900] and validation (AUC, 0.792; 95% CI, 0.633-0.952) cohorts.

Interpretation: DMMM can serve as a visual prognostic tool for DM prediction in NPC, and it can improve treatment decisions by aiding in the differentiation of patients with high and low risks of DM. FUND: This research received financial support from the National Natural Science Foundation of China (81571664, 81871323, 81801665, 81771924, 81501616, 81671851, and 81527805); the National Natural Science Foundation of Guangdong Province (2018B030311024); the Science and Technology Planning Project of Guangdong Province (2016A020216020); the Scientific Research General Project of Guangzhou Science Technology and Innovation Commission (201707010328); the China Postdoctoral Science Foundation (2016M600145); and the National Key R&D Program of China (2017YFA0205200, 2017YFC1308700, and 2017YFC1309100).

Citing Articles

Integrating mitochondrial and lysosomal gene analysis for breast cancer prognosis using machine learning.

Chen H, Wang Z, Shi J, Peng J Sci Rep. 2025; 15(1):3320.

PMID: 39865118 PMC: 11770110. DOI: 10.1038/s41598-025-86970-4.


F-NaF uptake in skull-base bone as a predictor of treatment response in advanced nasopharyngeal carcinoma.

Mu X, Li J, Huang J, Wang Z, Li Z, Li X Sci Rep. 2024; 14(1):29501.

PMID: 39604456 PMC: 11603326. DOI: 10.1038/s41598-024-81350-w.


Development and validation of a practical score to predict 3-year distant metastatic free survival in nasopharyngeal carcinoma incorporating the number of lymph node regions.

Jaruthien T, Lertbutsayanukul C, Jittapiromsak N, Sriyook A, Kulalert P, Tantiyavarong P PLoS One. 2024; 19(8):e0309436.

PMID: 39190649 PMC: 11349101. DOI: 10.1371/journal.pone.0309436.


Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma.

Sim Y, Sohn B, Kim S, Kim H, Hong M, Kim J Future Oncol. 2024; 20(36):2869-2878.

PMID: 38861311 PMC: 11572203. DOI: 10.1080/14796694.2024.2342226.


Construction and validation of an innovative prognostic nomogram for overall survival in cervical cancer patients with lung metastasis: an analysis utilizing the SEER database.

Chang L, Zhao K Front Oncol. 2024; 14:1397454.

PMID: 38779094 PMC: 11109392. DOI: 10.3389/fonc.2024.1397454.


References
1.
Camp R, Dolled-Filhart M, Rimm D . X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004; 10(21):7252-9. DOI: 10.1158/1078-0432.CCR-04-0713. View

2.
Ou S, Zell J, Ziogas A, Anton-Culver H . Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol. 2006; 18(1):29-35. DOI: 10.1093/annonc/mdl320. View

3.
Vickers A, Elkin E . Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006; 26(6):565-74. PMC: 2577036. DOI: 10.1177/0272989X06295361. View

4.
Vickers A, Cronin A, Elkin E, Gonen M . Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008; 8:53. PMC: 2611975. DOI: 10.1186/1472-6947-8-53. View

5.
Wang W, Twu C, Chen H, Jan J, Jiang R, Chao J . Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic/recurrent nasopharyngeal carcinoma. Clin Cancer Res. 2010; 16(3):1016-24. DOI: 10.1158/1078-0432.CCR-09-2796. View